Showing results (11-20 of 324) with videos related to
Sort By:
Pageof 33
Journal of Immunological Methods|December 4, 2001
CD40 ligand and lipopolysaccharide enhance the in vitro generation of melanoma-reactive T-cellsJohn F Toso, Rejean Lapointe, Patrick HwuNature Biotechnology|November 5, 2002
Dual-specific T cells combine proliferation and antitumor activityMichael H Kershaw, Jennifer A Westwood, Patrick HwuOncoimmunology|November 20, 2012
New insights on the role of CD8(+)CD57(+) T-cells in cancerRichard C Wu, Patrick Hwu, Laszlo G RadvanyiJournal of Translational Medicine|January 30, 2009
Summary of the primer on tumor immunology and the biological therapy of cancerYufeng Li, Shujuan Liu, Kim Margolin, et al.Cancer Discovery|February 10, 2021
Applications of CRISPR Genome Editing to Advance the Next Generation of Adoptive Cell Therapies for CancerSamantha M Fix, Amir A Jazaeri, Patrick HwuCancer Research|January 24, 2024
Chromatin Remodelers Are Regulators of the Tumor Immune MicroenvironmentApoorvi Chaudhri, Gregory Lizee, Patrick Hwu, et al.Journal for Immunotherapy of Cancer|December 18, 2015
Targeting the indoleamine 2,3-dioxygenase pathway in cancerYong Wha Moon, Joud Hajjar, Patrick Hwu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 18, 2006
Improving antitumor immune responses by circumventing immunoregulatory cells and mechanismsGregory Lizée, Laszlo G Radvanyi, Willem W Overwijk, et al.AJR. American Journal of Roentgenology|November 24, 2011
Radiologic manifestations of immune-related adverse events in patients with metastatic melanoma undergoing anti-CTLA-4 antibody therapyYulia Bronstein, Chaan S Ng, Patrick Hwu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2006
Immunosuppression in melanoma immunotherapy: potential opportunities for interventionGregory Lizée, Laszlo G Radvanyi, Willem W Overwijk, et al.Pageof 33